Torno Capital »

Celldex Therapeutics shares owned by Torno Capital

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Torno Capital from 13F filings

Historical chart of Torno Capital investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Torno Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Torno Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $180k 5.3k 33.99

More positions owned by Torno Capital

Scorpio Tankers SHS Call Option (STNG)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Nabors Industries SHS Put Option (NBR)
BlackRock Call Option (BLK)
Meta Platforms Cl A Call Option (META)
Abbvie Call Option (ABBV)
Alphabet Inc Cap Stk CL C (GOOG)
Extra Space Storage Call Option (EXR)
KB Home Put Option (KBH)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
AutoZone Put Option (AZO)
Zoetis Cl A Call Option (ZTS)
United Therapeutics Corporation Put Option (UTHR)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Vaxcyte Put Option (PCVX)

View all positions for Torno Capital

Top funds holding Celldex Therapeutics

BlackRock
BlackRock
Vanguard Group
Kynam Capital Management
Eventide Asset Management
Bellevue Group
T. Rowe Price Associates
State Street Corporation
Woodline Partners
T. Rowe Price Investment Management
Point72 Asset Management
Commodore Capital
Geode Capital Management
Rock Springs Capital Management
Jennison Associates

View all funds holding Celldex Therapeutics